CoChat

Mitochondrial Iron Metabolism: The Crucial Actors in Diseases

Open access
Duan, Geyan, Li, Jianjun, Duan, Yehui, Zheng, Changbing, Guo, Qiuping, Li, Fengna, Zheng, Jie, Yu, Jiayi, Zhang, Peiwen, Wan, Mengliao, Long, Cimin · 2022 · Molecules
Cited by 69

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Iron is a trace element necessary for cell growth, development, and cellular homeostasis, but insufficient or excessive level of iron is toxic. Intracellularly, sufficient amounts of iron are required for mitochondria (the center of iron utilization) to maintain their normal physiologic function. Iron deficiency impairs mitochondrial metabolism and respiratory activity, while mitochondrial iron overload promotes ROS production during mitochondrial electron transport, thus promoting potential disease development. This review provides an overview of iron homeostasis, mitochondrial iron metabolism, and how mitochondrial iron imbalances-induced mitochondrial dysfunction contribute to diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules28010029

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 130

  1. Dev, 2017, Overview of iron metabolism in health and disease, Hemodial. Int., 21, S6, 10.1111/hdi.12542 · DOI · Paper page
  2. Swaminathan, 2018, Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury, Nephron, 140, 156, 10.1159/000490808 · DOI
  3. Gao, 2021, Mitochondrial iron metabolism and its role in diseases, Clin. Chim. Acta, 513, 6, 10.1016/j.cca.2020.12.005 · DOI
  4. Levi, 2009, The role of iron in mitochondrial function, Biochim. Biophys. Acta, 1790, 629, 10.1016/j.bbagen.2008.09.008 · DOI · Paper page
  5. Choi, 2012, Duodenal reductase activity and spleen iron stores are reduced and erythropoiesis is abnormal in Dcytb knockout mice exposed to hypoxic conditions, J. Nutr., 142, 1929, 10.3945/jn.112.160358 · DOI
  6. Muir, 1985, Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice, Am. J. Physiol., 248, G376
  7. Xue, 2016, Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis, Cell Metab., 24, 447, 10.1016/j.cmet.2016.07.015 · DOI · Paper page
  8. Theil, 2012, Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments, J. Nutr., 142, 478, 10.3945/jn.111.145854 · DOI
  9. Troadec, 2010, Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux, Blood, 116, 4657, 10.1182/blood-2010-04-278614 · DOI · Paper page
  10. Strzyz, 2020, Iron expulsion by exosomes drives ferroptosis resistance, Nat. Rev. Mol. Cell Biol., 21, 4, 10.1038/s41580-019-0195-2 · DOI
  11. Wood, 2014, Guidelines for quantifying iron overload, Hematol. Am. Soc. Hematol. Educ. Program, 2014, 210, 10.1182/asheducation-2014.1.210 · DOI
  12. Li, 2020, Transferrin Receptor 1 Regulates Thermogenic Capacity and Cell Fate in Brown/Beige Adipocytes, Adv. Sci., 7, 1903366, 10.1002/advs.201903366 · DOI
  13. Rensvold, 2016, Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis, J. Biol. Chem., 291, 20827, 10.1074/jbc.M116.727701 · DOI
  14. Swenson, S.A., Moore, C.M., Marcero, J.R., Medlock, A.E., Reddi, A.R., and Khalimonchuk, O. (2020). From Synthesis to Utilization: The Ins and Outs of Mitochondrial Heme. Cells, 9. · DOI
  15. Pandey, 2019, Mitochondria export iron-sulfur and sulfur intermediates to the cytoplasm for iron-sulfur cluster assembly and tRNA thiolation in yeast, J. Biol. Chem., 294, 9489, 10.1074/jbc.RA119.008600 · DOI
  16. Zorov, 1997, Mitochondria revisited. Alternative functions of mitochondria, Biosci. Rep., 17, 507, 10.1023/A:1027304122259 · DOI
  17. Paul, 2017, Mitochondria and Iron: Current questions, Expert Rev. Hematol., 10, 65, 10.1080/17474086.2016.1268047 · DOI · Paper page
  18. Ward, 2019, Mitochondrial Iron in Human Health and Disease, Annu. Rev. Physiol., 81, 453, 10.1146/annurev-physiol-020518-114742 · DOI · Paper page
  19. Santambrogio, 2015, Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients, Neurobiol. Dis., 81, 144, 10.1016/j.nbd.2015.02.030 · DOI
  20. Tavsan, 2015, The Variations of Glycolysis and TCA Cycle Intermediate Levels Grown in Iron and Copper Mediums of Trichoderma harzianum, Appl. Biochem. Biotechnol., 176, 76, 10.1007/s12010-015-1535-0 · DOI
  21. Manceau, H., Ausseil, J., Masson, D., Feugeas, J.P., Sablonniere, B., Guieu, R., Puy, H., and Peoc’h, K. (2022). Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency. Nutrients, 14. · DOI
  22. Payne, 2011, The Heart in Friedreich’s Ataxia: Basic Findings and Clinical Implications, Prog. Pediatr. Cardiol., 31, 103, 10.1016/j.ppedcard.2011.02.007 · DOI
  23. Kusminski, 2020, A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive beta-Cell Hyperplasia, Diabetes, 69, 313, 10.2337/db19-0327 · DOI · Paper page
  24. Nankivell, 1992, Iron accumulation in human chronic renal disease, Am. J. Kidney Dis., 20, 580, 10.1016/S0272-6386(12)70222-6 · DOI
  25. Mezzaroba, 2019, The role of zinc, copper, manganese and iron in neurodegenerative diseases, Neurotoxicology, 74, 230, 10.1016/j.neuro.2019.07.007 · DOI · Paper page
  26. Mostile, 2017, Iron and Parkinson’s disease: A systematic review and meta-analysis, Mol. Med. Rep., 15, 3383, 10.3892/mmr.2017.6386 · DOI
  27. Bajbouj, 2017, Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cycle arrest in MCF-7 cells, Tumour Biol., 39, 1010428317726184, 10.1177/1010428317726184 · DOI
  28. Chen, 2014, Cardiac mitochondria and reactive oxygen species generation, Circ. Res., 114, 524, 10.1161/CIRCRESAHA.114.300559 · DOI · Paper page
  29. Gammella, 2015, Iron-induced damage in cardiomyopathy: Oxidative-dependent and independent mechanisms, Oxid. Med. Cell. Longev., 2015, 230182, 10.1155/2015/230182 · DOI
  30. Melenovsky, 2017, Myocardial iron content and mitochondrial function in human heart failure: A direct tissue analysis, Eur. J. Heart Fail., 19, 522, 10.1002/ejhf.640 · DOI · Paper page
  31. Loncar, 2021, Iron deficiency in heart failure, ESC Heart Fail., 8, 2368, 10.1002/ehf2.13265 · DOI
  32. Ebner, 2019, Iron Deficiency in Heart Failure: An Overview, JACC Heart Fail., 7, 36, 10.1016/j.jchf.2018.07.015 · DOI · Paper page
  33. Chopra, 2020, Anaemia, iron deficiency and heart failure in 2020: Facts and numbers, ESC Heart Fail., 7, 2007, 10.1002/ehf2.12797 · DOI
  34. Rineau, 2018, Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model, Int. J. Cardiol., 266, 206, 10.1016/j.ijcard.2018.02.021 · DOI
  35. Vinchi, 2020, Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction, Eur. Heart J., 41, 2681, 10.1093/eurheartj/ehz112 · DOI · Paper page
  36. Whitnall, 2008, The MCK mouse heart model of Friedreich’s ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation, Proc. Natl. Acad. Sci. USA, 105, 9757, 10.1073/pnas.0804261105 · DOI · Paper page
  37. Gao, 2010, Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload, Free Radic. Biol. Med., 49, 401, 10.1016/j.freeradbiomed.2010.04.033 · DOI
  38. Chang, 2016, Reduction in mitochondrial iron alleviates cardiac damage during injury, EMBO Mol. Med., 8, 247, 10.15252/emmm.201505748 · DOI · Paper page
  39. Aracil, 2011, Combined therapy with idebenone and deferiprone in patients with Friedreich’s ataxia, Cerebellum, 10, 1, 10.1007/s12311-010-0212-7 · DOI
  40. Ichikawa, 2012, Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export, Proc. Natl. Acad. Sci. USA, 109, 4152, 10.1073/pnas.1119338109 · DOI · Paper page
  41. Elas, 2008, Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy, Free Radic. Biol. Med., 45, 321, 10.1016/j.freeradbiomed.2008.04.016 · DOI
  42. Galvano, 2010, Oxidative stress in normal-weight obese syndrome, Obesity, 18, 2125, 10.1038/oby.2010.50 · DOI
  43. Grattagliano, 2008, Oxidative stress-induced risk factors associated with the metabolic syndrome: A unifying hypothesis, J. Nutr. Biochem., 19, 491, 10.1016/j.jnutbio.2007.06.011 · DOI · Paper page
  44. Itabe, 2011, The Dynamics of Oxidized LDL during Atherogenesis, J. Lipids, 2011, 418313, 10.1155/2011/418313 · DOI
  45. Fantuzzi, 2007, Adipose tissue and atherosclerosis: Exploring the connection, Arterioscler. Thromb. Vasc. Biol., 27, 996, 10.1161/ATVBAHA.106.131755 · DOI · Paper page
  46. Larque, 2010, Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects, J. Physiol. Biochem., 66, 221, 10.1007/s13105-010-0028-4 · DOI
  47. Carraro, 2014, Intake of red wine in different meals modulates oxidized LDL level, oxidative and inflammatory gene expression in healthy people: A randomized crossover trial, Oxid. Med. Cell. Longev., 2014, 681318
  48. Ponikowski, 2015, Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger, Eur. Heart J., 36, 657, 10.1093/eurheartj/ehu385 · DOI · Paper page
  49. Valenti, 2010, HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease, Gastroenterology, 138, 905, 10.1053/j.gastro.2009.11.013 · DOI · Paper page
  50. Pietrangelo, 1996, Metals, oxidative stress, and hepatic fibrogenesis, Semin. Liver Dis., 16, 13, 10.1055/s-2007-1007215 · DOI · Paper page
  51. Pietrangelo, 2015, Pathogens, Metabolic Adaptation, and Human Diseases—An Iron-Thrifty Genetic Model, Gastroenterology, 149, 834, 10.1053/j.gastro.2015.08.003 · DOI
  52. Ikeda, 2016, Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway, J. Trace Elem. Med. Biol., 35, 66, 10.1016/j.jtemb.2016.01.011 · DOI · Paper page
  53. Kramer, 2017, Extensive Type II Muscle Fiber Atrophy in Elderly Female Hip Fracture Patients, J. Gerontol. A Biol. Sci. Med. Sci., 72, 1369, 10.1093/gerona/glw253 · DOI
  54. Sayed, 2016, Identification of morphological markers of sarcopenia at early stage of aging in skeletal muscle of mice, Exp. Gerontol., 83, 22, 10.1016/j.exger.2016.07.007 · DOI
  55. Altun, 2007, Iron load and redox stress in skeletal muscle of aged rats, Muscle Nerve, 36, 223, 10.1002/mus.20808 · DOI · Paper page
  56. Xu, J., Knutson, M.D., Carter, C.S., and Leeuwenburgh, C. (2008). Iron accumulation with age, oxidative stress and functional decline. PLoS ONE, 3. · DOI · Paper page
  57. Kasztura, 2017, Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes, Kardiol. Pol., 75, 267, 10.5603/KP.a2016.0155 · DOI
  58. Ding, 2021, Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis, J. Cachexia Sarcopenia Muscle, 12, 746, 10.1002/jcsm.12700 · DOI · Paper page
  59. Perna, 2017, Sarcopenia and sarcopenic obesity in comparison: Prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly, Aging Clin. Exp. Res., 29, 1249, 10.1007/s40520-016-0701-8 · DOI
  60. Kim, T.H., Hwang, H.J., and Kim, S.H. (2014). Relationship between Serum Ferritin Levels and Sarcopenia in Korean Females Aged 60 Years and Older Using the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008–2009. PLoS ONE, 9. · DOI
  61. Xu, 2012, Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy, Exp. Gerontol., 47, 100, 10.1016/j.exger.2011.10.011 · DOI · Paper page
  62. Argiles, 2014, Cachexia: A problem of energetic inefficiency, J. Cachexia Sarcopenia Muscle, 5, 279, 10.1007/s13539-014-0154-x · DOI · Paper page
  63. Borkowska, 2019, Iron Metabolism of the Skeletal Muscle and Neurodegeneration, Front. Neurosci., 13, 165, 10.3389/fnins.2019.00165 · DOI
  64. Reardon, 2009, Iron injections in mice increase skeletal muscle iron content, induce oxidative stress and reduce exercise performance, Exp. Physiol., 94, 720, 10.1113/expphysiol.2008.046045 · DOI
  65. Kobak, 2018, Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions, Int. J. Mol. Med., 41, 2678
  66. Zhang, 2019, Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting, J. Cachexia Sarcopenia Muscle, 10, 557, 10.1002/jcsm.12414 · DOI
  67. Ikeda, 2022, The role of iron in obesity and diabetes, J. Med. Investig., 69, 1, 10.2152/jmi.69.1 · DOI
  68. Yan, 2018, Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice, Endocr. Connect., 7, 604, 10.1530/EC-18-0054 · DOI · Paper page
  69. Orr, 2014, Obesity alters adipose tissue macrophage iron content and tissue iron distribution, Diabetes, 63, 421, 10.2337/db13-0213 · DOI · Paper page
  70. Tajima, 2012, Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice, Am. J. Physiol. Endocrinol. Metab., 302, E77, 10.1152/ajpendo.00033.2011 · DOI · Paper page
  71. Xue, 2016, Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice, Ann. N. Y. Acad. Sci., 1375, 52, 10.1111/nyas.13174 · DOI
  72. Blesia, V., Patel, V.B., Al-Obaidi, H., Renshaw, D., and Zariwala, M.G. (2021). Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells. Cells, 10. · DOI
  73. Qiu, 2022, The role of iron metabolism in chronic diseases related to obesity, Mol. Med., 28, 130, 10.1186/s10020-022-00558-6 · DOI
  74. Ortega, 2014, Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis, Diabetologia, 57, 1957, 10.1007/s00125-014-3298-5 · DOI
  75. 2012, Mitochondria and endocrine function of adipose tissue, Best Pract. Res. Clin. Endocrinol. Metab., 26, 791, 10.1016/j.beem.2012.06.002 · DOI
  76. Rumberger, 2004, Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes, Diabetes, 53, 2535, 10.2337/diabetes.53.10.2535 · DOI · Paper page
  77. Rajpathak, 2009, Biomarkers of body iron stores and risk of developing type 2 diabetes, Diabetes Obes. Metab., 11, 472, 10.1111/j.1463-1326.2008.00985.x · DOI · Paper page
  78. Liu, 2018, Renal tubule injury: A driving force toward chronic kidney disease, Kidney Int., 93, 568, 10.1016/j.kint.2017.09.033 · DOI · Paper page
  79. Baliga, 1993, Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys, Biochem. J., 291, 901, 10.1042/bj2910901 · DOI · Paper page
  80. Baliga, 1998, In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity, Kidney Int., 53, 394, 10.1046/j.1523-1755.1998.00767.x · DOI · Paper page
  81. Wish, 2018, Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?, Am. J. Nephrol., 47, 72, 10.1159/000486968 · DOI
  82. Wetzels, 2020, The multifaceted role of iron in renal health and disease, Nat. Rev. Nephrol., 16, 77, 10.1038/s41581-019-0197-5 · DOI · Paper page
  83. ElAlfy, 2018, Renal iron deposition by magnetic resonance imaging in pediatric beta-thalassemia major patients: Relation to renal biomarkers, total body iron and chelation therapy, Eur. J. Radiol., 103, 65, 10.1016/j.ejrad.2018.04.007 · DOI
  84. Tang, 2020, Ferroptosis and kidney diseases, Int. Urol. Nephrol., 52, 497, 10.1007/s11255-019-02335-7 · DOI
  85. Dixon, 2012, Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
  86. Wang, 2020, Mitochondria regulation in ferroptosis, Eur. J. Cell Biol., 99, 151058, 10.1016/j.ejcb.2019.151058 · DOI · Paper page
  87. Deng, 2020, Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity, Front. Pharmacol., 11, 624529, 10.3389/fphar.2020.624529 · DOI
  88. Bhat, 2015, Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight, Biomed. Pharmacother., 74, 101, 10.1016/j.biopha.2015.07.025 · DOI · Paper page
  89. Moos, 2004, The metabolism of neuronal iron and its pathogenic role in neurological disease: Review, Ann. N. Y. Acad. Sci., 1012, 14, 10.1196/annals.1306.002 · DOI · Paper page
  90. Islam, 2017, Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders, Neurol. Res., 39, 73, 10.1080/01616412.2016.1251711 · DOI · Paper page
  91. Federico, 2012, Mitochondria, oxidative stress and neurodegeneration, J. Neurol. Sci., 322, 254, 10.1016/j.jns.2012.05.030 · DOI · Paper page
  92. Ward, 2015, Ageing, neuroinflammation and neurodegeneration, Front. Biosci. Schol. Ed., 7, 189, 10.2741/s433 · DOI · Paper page
  93. Posadas, 2018, Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress, Antioxid. Redox Signal., 28, 1669, 10.1089/ars.2017.7272 · DOI · Paper page
  94. Quintana, 2004, Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin, J. Struct. Biol., 147, 166, 10.1016/j.jsb.2004.03.001 · DOI · Paper page
  95. Cheng, 2022, Mitochondrial iron metabolism and neurodegenerative diseases, Neurotoxicology, 88, 88, 10.1016/j.neuro.2021.11.003 · DOI
  96. Worwood, 1982, Ferritin in human tissues and serum, Clin. Haematol., 11, 275, 10.1016/S0308-2261(21)00338-6 · DOI
  97. Powell, 1975, Human isoferritins: Organ specific iron and apoferritin distribution, Br. J. Haematol., 30, 47, 10.1111/j.1365-2141.1975.tb00516.x · DOI
  98. Zhang, 2021, New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases, Mol. Neurobiol., 58, 2812, 10.1007/s12035-020-02277-7 · DOI · Paper page
  99. Bossoni, 2017, Human-brain ferritin studied by muon spin rotation: A pilot study, J. Phys. Condens. Matter, 29, 415801, 10.1088/1361-648X/aa80b3 · DOI
  100. Strbak, 2020, Quantitative Analysis of Magnetoferritin-Induced Relaxivity Enhancement in MRI, Acta Phys. Pol. A, 137, 720, 10.12693/APhysPolA.137.720 · DOI
  101. 2014, Early onset Alzheimer’s disease and oxidative stress, Oxid. Med. Cell. Longev., 2014, 375968
  102. Huang, 1999, The A beta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry, 38, 7609, 10.1021/bi990438f · DOI · Paper page
  103. Pratico, 2004, 12/15-lipoxygenase is increased in Alzheimer’s disease: Possible involvement in brain oxidative stress, Am. J. Pathol., 164, 1655, 10.1016/S0002-9440(10)63724-8 · DOI · Paper page
  104. Yang, 2010, Amelioration of the Alzheimer’s disease phenotype by absence of 12/15-lipoxygenase, Biol. Psychiatry, 68, 922, 10.1016/j.biopsych.2010.04.010 · DOI
  105. Feeney, 2008, Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices, Brain Res., 1198, 1, 10.1016/j.brainres.2007.12.049 · DOI
  106. Rubinsztein, 2003, Huntington’s disease: Molecular basis of neurodegeneration, Expert Rev. Mol. Med., 5, 1, 10.1017/S1462399403006549 · DOI · Paper page
  107. Shi, 2010, Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: Implication for neuroprotection in Parkinson’s disease, Antioxid. Redox Signal., 13, 783, 10.1089/ars.2009.3018 · DOI · Paper page
  108. Guan, 2017, Mitochondrial ferritin protects SH-SY5Y cells against H2O2-induced oxidative stress and modulates alpha-synuclein expression, Exp. Neurol., 291, 51, 10.1016/j.expneurol.2017.02.001 · DOI
  109. Mizuno, 1995, Role of mitochondria in the etiology and pathogenesis of Parkinson’s disease, Biochim. Biophys. Acta, 1271, 265, 10.1016/0925-4439(95)00038-6 · DOI · Paper page
  110. Munoz, 2016, Parkinson’s Disease: The Mitochondria-Iron Link, Park. Dis., 2016, 7049108
  111. Carroll, 2011, Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease, Neurochem. Int., 59, 73, 10.1016/j.neuint.2011.05.006 · DOI
  112. Mena, 2015, The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death, Biochem. Biophys. Res. Commun., 463, 787, 10.1016/j.bbrc.2015.06.014 · DOI
  113. Ludwig, 2015, Iron metabolism and iron supplementation in cancer patients, Wien. Klin. Wochenschr., 127, 907, 10.1007/s00508-015-0842-3 · DOI
  114. Bystrom, 2015, Cancer cells with irons in the fire, Free Radic. Biol. Med., 79, 337, 10.1016/j.freeradbiomed.2014.04.035 · DOI · Paper page
  115. Biasiotto, 2020, The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against SARS-CoV-2 infection (COVID-19): A role for iron homeostasis?, Pharmacol. Res., 158, 104904, 10.1016/j.phrs.2020.104904 · DOI
  116. Cerqueira, 2007, Ribonucleotide reductase: A critical enzyme for cancer chemotherapy and antiviral agents, Recent Pat. Anticancer Drug Discov., 2, 11, 10.2174/157489207779561408 · DOI
  117. Kong, 2022, BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance, Redox Biol., 54, 102356, 10.1016/j.redox.2022.102356 · DOI
  118. Hooda, J., Cadinu, D., Alam, M.M., Shah, A., Cao, T.M., Sullivan, L.A., Brekken, R., and Zhang, L. (2013). Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells. PLoS ONE, 8. · DOI · Paper page
  119. Basuli, 2017, Iron addiction: A novel therapeutic target in ovarian cancer, Oncogene, 36, 4089, 10.1038/onc.2017.11 · DOI · Paper page
  120. Zhang, 2020, Pan-cancer analysis of iron metabolic landscape across the Cancer Genome Atlas, J. Cell Physiol., 235, 1013, 10.1002/jcp.29017 · DOI
  121. Xue, 2015, Decreased expression of ferroportin in prostate cancer, Oncol. Lett., 10, 913, 10.3892/ol.2015.3363 · DOI
  122. Pinnix, 2010, Ferroportin and iron regulation in breast cancer progression and prognosis, Sci. Transl. Med., 2, 43ra56, 10.1126/scitranslmed.3001127 · DOI · Paper page
  123. Guo, 2015, An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis, Acta Biochim. Biophys. Sin., 47, 703, 10.1093/abbs/gmv063 · DOI · Paper page
  124. Shan, 2018, Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells, Toxicol. Appl. Pharmacol., 356, 36, 10.1016/j.taap.2018.07.017 · DOI
  125. Hung, 2013, Mitoferrin-2-dependent mitochondrial iron uptake sensitizes human head and neck squamous carcinoma cells to photodynamic therapy, J. Biol. Chem., 288, 677, 10.1074/jbc.M112.422667 · DOI · Paper page
  126. Lui, 2015, Targeting cancer by binding iron: Dissecting cellular signaling pathways, Oncotarget, 6, 18748, 10.18632/oncotarget.4349 · DOI · Paper page
  127. Estrov, 1987, In vitro and in vivo effects of deferoxamine in neonatal acute leukemia, Blood, 69, 757, 10.1182/blood.V69.3.757.757 · DOI · Paper page
  128. Abdelaal, 2021, Reversing oncogenic transformation with iron chelation, Oncotarget, 12, 106, 10.18632/oncotarget.27866 · DOI
  129. Lesjak, 2019, Quercetin inhibits intestinal non-haem iron absorption by regulating iron metabolism genes in the tissues, Eur. J. Nutr., 58, 743, 10.1007/s00394-018-1680-7 · DOI
  130. Chen, 2020, CN128: A New Orally Active Hydroxypyridinone Iron Chelator, J. Med. Chem., 63, 4215, 10.1021/acs.jmedchem.0c00137 · DOI

Cited by

Metadata

Authors
Duan, G., Li, J., Duan, Y., Zheng, C., Guo, Q., Li, F., Zheng, J., Yu, J., Zhang, P., Wan, M., & Long, C.
Venue
Molecules
Publisher
MDPI AG
Published
2022-12-21
Volume
28
Issue
1
Pages
29
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4313502820
Cited by
69
References
48
FWCI
6.24
Type
journal article
Language
en
Open access
gold
Funders
  • Natural Science Foundation of Hunan Province (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
  • Changsha Natural Science Funds for Distinguished Young Scholar (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
  • Science and Technology Innovation Program of Hunan Province (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
  • National Key Research and Development Programs of China (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)
  • China Agriculture Research System of MOF and MARA (2021JJ20044, kq2009020, 2022RC1159, 2022YFD1300503, CARS-35)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.